The latest news for pharma industry insiders.
The Rise of GLP-1 Drugs and the Challenges of Proper Disposal
With great power comes great responsibility. In this case, tackling these obstacles is vital to making sure that the positives of GLP-1s are not outweighed by the downfalls of improper waste disposal.
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years later according to Prime Therapeutics’ real-world evidence, says Ben Urick, Pharm.D., Ph.D., a health outcomes researcher for the pharmacy benefit manager.
What’s at Stake in a Strained Microsoft-OpenAI Partnership
The alliance between the technology giant and the company behind OpenAI has been hugely consequential — but a disruption could shake up the A.I. race.
PharmaJet announced that they will share their latest research results at the World Vaccine Congress – Europe on October 29, 2024 at 1:40 pm GMT. The presentation, entitled Improving Performance of Vaccines with Needle-free Technology will be presented by Nathalie Landry, Chief Scientific Officer, PharmaJet.
Thanks to Pharmaceutical Executive for naming us amongst this year's Finalists for the upcoming APEX AWARDS.
It is an honor to be recognized for another immersive multimedia tactical integration designed and developed for an incredible client. This #augmentedreality program was produced using many specialized production techniques, including #volumetricvideo capture, to deploy multiple 3D holograms of prominent clinicians merged with interactive animated digital elements to deliver vibrant and engaging 3D presentations that empowered representatives and distinguished the brand.
Congratulations to all Finalists >>https://lnkd.in/eAgJcSs9
#ImmersiveMultimedia #PharmaMarketing #AR #VR #Confideo
CC ::Matt Irwin,Chad Capeland,Mike Marett,Darlene P.,Marc Russo,Cedric "Jamie" Rutland MD FCCP,Alvin Wells, MD, PhD,Glenn Thorpe
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs